Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain.
Weber
Karl T
KT
D000318:Adrenergic beta-Agonists / Q000494:pharmacology / Q000627:therapeutic use; D000450:Aldosterone / Q000378:metabolism; D000818:Animals; D004232:Diuretics / Q000494:pharmacology* / Q000627:therapeutic use*; D004573:Electrolytes / Q000378:metabolism; D005665:Furosemide / Q000494:pharmacology* / Q000627:therapeutic use*; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000187:drug effects; D013995:Time; D014463:Ultrasonography; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism
D000318:Adrenergic beta-Agonists; D004232:Diuretics; D004573:Electrolytes; D018377:Neurotransmitter Agents; D000450:Aldosterone; D005665:Furosemide